PAX6 and gastric cancer: In this study, it was found that PAX6 was negatively associated with the survival of patients with GC, indicating an oncogenic role of PAX6 in GC, which is consistent with the previously reported role of PAX6 in lung adenocarcinoma and pancreatic cancer.13